NutriBand (NTRB) Total Current Liabilities (2016 - 2026)
NutriBand's (NTRB) quarterly Total Current Liabilities came in at $784281.0 in Q1 2026, down 20.2% year-on-year from $982845.0 in Q1 2025, and up 1.52% quarter-over-quarter from $772524.0 in Q4 2025.
NutriBand (NTRB) Total Current Liabilities (2016 - 2026) Analysis & Trends
NutriBand has disclosed Total Current Liabilities across 11 years of filings, most recently posting $784281.0 for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $784281.0, down 20.2% year-over-year; the trailing twelve-month figure through Jan 2026 was $784281.0 (down 20.2% YoY), and the FY2026 annual result was $784281.0, down 20.2% from the prior year.
- Total Current Liabilities came in at $784281.0 for Q1 2026 at NutriBand, up from $772524.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q3 2025 to a low of $717774.0 in Q4 2023.
- The 5-year median for Total Current Liabilities is $803924.0 (2022), against an average of $942631.3.
- Across the five-year window, Total Current Liabilities sank 71.33% in 2022 and soared 80.63% in 2024, its largest moves.
- NutriBand's Total Current Liabilities stood at $789752.0 in 2022, then decreased by 9.11% to $717774.0 in 2023, then surged by 73.84% to $1.2 million in 2024, then sank by 38.09% to $772524.0 in 2025, then gained by 1.52% to $784281.0 in 2026.
- The last three Total Current Liabilities figures came in at $784281.0 (Q1 2026), $772524.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 72.86 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 784,281.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 784,281.00 |
| Oct 31, 2025 | 772,524.00 |
| Jul 31, 2025 | 1.57 Mn |
| Apr 30, 2025 | 925,051.00 |
| Jan 31, 2025 | 982,845.00 |
| Oct 31, 2024 | 1.25 Mn |
| Jul 31, 2024 | 1.10 Mn |
| Apr 30, 2024 | 1.42 Mn |
| Jan 31, 2024 | 999,093.00 |
| Oct 31, 2023 | 717,774.00 |
| Jul 31, 2023 | 874,127.00 |
| Apr 30, 2023 | 784,393.00 |
| Jan 31, 2023 | 748,613.00 |
| Oct 31, 2022 | 789,752.00 |
| Jul 31, 2022 | 803,924.00 |
| Apr 30, 2022 | 723,057.00 |
| Jan 31, 2022 | 779,256.00 |
| Oct 31, 2021 | 1.00 Mn |
| Jul 31, 2021 | 2.66 Mn |
| Apr 30, 2021 | 2.52 Mn |